Novel acrylate compounds demonstrate strong antifungal and antibacterial properties, indicating their potential as drug candidates.
Novel acrylate derivatives ( 1-4) were synthesized by Knoevenagel condensation of thiophene-2-carbaldehyde with malononitrile, cyanoacetamide, ethyl cyanoacetate and isobutyl cyanoacetate in the presence of ammonium acetate (NH 4 OAc) using microwave irradiation under solvent-free conditions. The reactions were completed in 30 sec with excellent yield. All the synthesized compounds were characterized by FT-IR, and NMR ( 1 H, 13 C, DEPT-135) analyses. The biological assays revealed that analog 3 had the highest antibacterial activity against Salmonella typhi (7.5 ± 0.33 mm), while analog 2 demonstrated the strongest antifungal effect against Aspergillus niger (90.33 ± 0.23 mm) and Aspergillus flavous (89.55 ± 0.33 mm). Some analogs exhibited no activity against Staphylococcus hominis and Shigella flexneri . Additionally, molecular docking studies indicated that analog 4 had the strongest interaction with the fungal receptor ( PDB: 5V5Z ), supporting the observed biological activities. The molecular dynamics simulation was performed against Lanosterol 14-alpha demethylase (LDM) (PDB ID: 5V5Z; organism: Candida albicans ) to investigate the binding stability and interactions between the drug and targeted protein. The outcome of the antimicrobial activity and in-silico analysis assessment of the compounds demonstrated significant effectiveness, supporting their selection as potential antifungal drug candidates.
No takes yet. Share an insight, caveat, or question.
Bhuiyan et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: